- Home
- SRAD vs MIR Comparison
SRAD vs MIR Comparison
Compare SRAD & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRAD | MIR |
|---|---|---|
| Founded | 2001 | 2005 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Industrial Machinery/Components |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 6.2B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | SRAD | MIR |
|---|---|---|
| Price | $18.34 | $21.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 17 | 8 |
| Target Price | ★ $30.18 | $28.38 |
| AVG Volume (30 Days) | 2.2M | ★ 3.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $24.65 | $24.05 |
| Revenue Next Year | $15.05 | $7.40 |
| P/E Ratio | ★ $49.48 | $195.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.73 | $12.00 |
| 52 Week High | $32.22 | $30.28 |
Technical Indicators
Market Signals| Indicator | SRAD | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 49.31 | 45.03 |
| Support Level | $16.21 | $19.76 |
| Resistance Level | $19.67 | $22.53 |
| Average True Range (ATR) | 0.87 | 0.82 |
| MACD | 0.20 | 0.12 |
| Stochastic Oscillator | 53.87 | 66.21 |
Price Performance
Historical ComparisonAbout SRAD Sportradar Group AG
Sportradar Group AG is a technology platform enabling next-generation engagement in sports, and a provider of B2B solutions to the sports betting industry. It generates revenue through two primary sources: subscription-based revenue and revenue sharing. Geographically, it operates in North America, Africa, AsiaPac & Middle East, Europe, and LATAM & Caribbean.
About MIR Mirion Technologies Inc.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.